Tempest Therapeutics, Inc. (TPST)

SEC filing

Tempest Therapeutics, Inc.

TPST · CIK 1544227

4 · Oct 2, 2026 · Director Smith Nancy Freda was granted 25K Stock Option (right to buy)

Director Smith Nancy Freda was granted 25K Stock Option (right to buy)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.